ProSciento, Inc.’s Post

According to a recent study performed in #sweden nearly one-fifth of people had #diabeticretinopathy (DR) at the time of type 2 diabetes (T2D) diagnosis. The prevalence of DR was higher in men, those born outside of Sweden, and those with a history of stroke, kidney disease, and high systolic blood pressure (SBP). This indicates two noticeable facts: 1. Longstanding hyperglycemia 2. The need for intensified screening for T2D in clinical practice For the authors, "Further research is needed to develop efficient strategies and programs to not only screen for T2D at random in clinical practice but also more structured screening to detect T2D earlier." Early detection is key. At #curalife, we couldn't agree more. #type2diabetes #metabolicheath #preventivemedicine #curalife

#Hypertension is a silent disease affecting millions worldwide. After the World Hypertension Day earlier this month, I wanted to emphasize the importance of awareness and action in combating this global health issue. At Servier, we are committed to advancing the prevention, diagnosis, and treatment of hypertension. For the past seven years, we have been dedicated to enhancing hypertension screening through our #BecauseISaySo global awareness campaign. This initiative aims to provide patients with the necessary information and tools to make regular blood pressure monitoring a habitual practice. Together, we can make a significant impact on reducing the burden of hypertension. #BeTheCaptainOfYourLife by #CheckYourBloodPressure regularly 💪 #BecauseIsayso Corina Jarquin Chems Eddine DJEGHLAL Liliana Alvarado Arévalo Michael van der Walt Caroline GIACOMONI (BELLAICHE) Anne VENOT Learn more here: https://lnkd.in/em5W7qBP

🌿🧠 A New Approach? GLP-1 Medication shows promise in Parkinson's Disease 🌟💊 A recent article in Nature illuminates a promising avenue in the fight against Parkinson's disease. GLP-1 medications, commonly used for diabetes management and hyper-popular for weight loss, are now revealing potential benefits in slowing the progression of Parkinson's disease. While still early in this clinical research pathway, it is truly amazing to see the growing number of disease processes that are positively impacted by the GLP-1 medication class. (See link to source in comments) #GLP1 #Parkinsons #Innovation #MetabolicHealth

A recent review of 80 RCTs and 14 types of autoimmune disease found that gut microbiota-based therapies may improve the symptoms and/or inflammatory status of a variety of conditions: https://lnkd.in/geDkuYtv Omni-Biotic formulations have been clinically studied to improve biochemical and inflammatory markers related to autoimmune conditions. Healthcare practitioners are welcome to request samples at: omnibioticlife.com/samples #autoimmunedisease #diabetes #SLE #Sjogrenssyndrome

It is getting very exciting in this space and if the plans of NN & Lilly work out, the practice of medicine will be quite different in a few years, and rightfully so. It is time to recognize the role excess fat plays in the pathogenesis of many diseases and its impact on health and healthspan. #obesity #glp1 #healthspan

Happy World Diabetes Day! Today we celebrate the progress made in diabetes research, management, and treatment. Let's give thanks to all who help improve the lives of those affected by this chronic disease. In the latest issue, OTR readers can find a useful primer on headline-grabbing weight-loss therapies based on drugs approved for Type 2 diabetes. #WorldDiabetesDay https://ow.ly/gOQ050PWOpF

✨From connected insulin pens to personalized treatment plans, Novo Nordisk is harnessing the power of digital technology to transform diabetes care. Learn more at our new site that will give a glimpse into some of the things we work with in Novo Nordisk.✨ An insight in how far we have come in a 100 years and what is still to be learned to further improve the lives of people living with serious chronic disease.  #novonordisk #datascience #realworlddata #techlifenovonordisk #Digitalcareers

📰 Exciting News in Medical Research! 📰 Did you know that the diabetes drug Metformin may have the potential to stop gum disease? Recent studies have uncovered promising results that could revolutionize the way we approach oral health and diabetes treatment. Read this insightful article to learn more about the groundbreaking research and its implications for patients with diabetes and gum disease: Diabetes Drug Metformin May Stop Gum Disease ✨ Key Highlights: The potential dual benefits of Metformin Insights from recent studies Implications for future treatment approaches Stay informed and explore how this discovery could change lives and improve overall health. Follow https://lnkd.in/gi7pj8kH to read the complete article at #aestheticmedicalpractitionermagazine. #MedicalResearch #Metformin #GumDisease #DiabetesTreatment #InnovativeHealth #AestheticMedicalPractitioner #aestheticmedicine #aestheticmedicinenews #aestheticmedicalpractitioner #cosmeticsurgery #plasticsurgery

Today at the J.P. Morgan #Healthcare Conference we presented how we plan to improve cardiometabolic health with a new class of investigational therapies calledcontrolled metabolic accelerators or CMAs that focus on energy expenditure instead of energy intake by controlling the acceleration of basal metabolism. We look forward to continuing the conversation with those at the forefront of enhancing the well-being of people living with #obesityassociated metabolic diseases. #JPM24

Obesity is a chronic cardiometabolic endocrine disease. There’s dysfunction between the brain and the gut, and now there are medications that are extremely effective at treating that chronic disease. How can we combine GLP-1 therapeutics with other therapies or lifestyle management programs that can help an individual experience sustained change? The healthcare industry needs to further help individuals learn healthy behaviors in conjunction with GLP-1 therapeutics. Lifestyle management programs that are out there are showing that they’re effective. People have learned how their bodies react to food, what’s good for them, what’s not good for them, and that is just such a better outcome. It’s more affordable, but it’s also sustainable, it’s empowering, and it gets at the root cause of the issue. #obesity #healthandwellness #weightloss